Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Lung Neoplasms 2Barrett Esophagus 2Triple Negative Breast Neoplasms 1Thyroid Nodule 1Stomach Neoplasms 1Rectal Neoplasms 1Neoplasm Metastasis 1Liver Cirrhosis 1Hypertension, Portal 1Gastrointestinal Neoplasms 1Fibrosis 1Cysts 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Calcinosis 1Breast Neoplasms 1Breast Cyst 1Arachnodactyly 1Adenocarcinoma of Lung 1

Interventions

tremelimumab 1epigallocatechin gallate 1durvalumab 1babao dan 1Urination 1Standard of Care 1Rosuvastatin Calcium 1Preoperative Exercise 1Furosemide 1Erlotinib Hydrochloride 1Digoxin 1Diagnostic Imaging 1Control Groups 1Cannabidiol 1Breathing Exercises 1Breath Tests 1Blood Specimen Collection 1Aspirin 1Anti-HIV Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Cirrhosis × Diagnostic Imaging × 1 year × Clear all
NCT06265272 2025-09-26

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

Massachusetts General Hospital

Recruiting
45 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡